1
|
Popat A, Patel AA, Warnes G. Cell Cycle Analysis of ER Stress and Autophagy. Methods Mol Biol 2022; 2543:155-166. [PMID: 36087266 DOI: 10.1007/978-1-0716-2553-8_13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Autophagy and ER stress are most often studied employing a Western blotting approach to the measurement of autophagy by LC3B upregulation and the ER stress sensor signaling proteins PERK (protein kinase R-like endoplasmic reticulum kinase), IRE1, and ATF6 which initiate protein refolding and elongation of the ER until ER homeostasis is returned. If the misfolding of proteins is increased, then ER stress is maintained, and microautophagy of the ER or specifically reticulophagy occurs. However, LC3B, PERK, protein misfolding, and changes in ER mass (reticulophagy) can also be measured in a cell cycle-dependent manner by flow cytometry and the use of antibodies, protein misfolding, and ER tracking fluorescent probes.
Collapse
Affiliation(s)
- A Popat
- Flow Cytometry Core Facility, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary London University, London, UK
| | - A A Patel
- Flow Cytometry Core Facility, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary London University, London, UK
| | - Gary Warnes
- Flow Cytometry Core Facility, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary London University, London, UK.
| |
Collapse
|
2
|
Ichkhanian Y, Vosoughi K, Aghaie Meybodi M, Jacques J, Sethi A, Patel AA, Aadam AA, Triggs JR, Bapaye A, Dorwat S, Benias P, Chaves DM, Barret M, Law RJ, Browers N, Pioche M, Draganov PV, Kotzev A, Estremera F, Albeniz E, Ujiki MB, Callahan ZM, Itani MI, Brewer OG, Khashab MA. Correction to: Comprehensive analysis of adverse events associated with gastric peroral endoscopic myotomy: an international multicenter study. Surg Endosc 2020; 35:1765. [PMID: 32424623 DOI: 10.1007/s00464-020-07651-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- Y Ichkhanian
- Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA
| | - K Vosoughi
- Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA
| | - M Aghaie Meybodi
- Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA
| | - J Jacques
- Gastroenterology Department, Limoges University Hospital, 2 Avenue Martin Luther King, 87042, Rouen, France
| | - A Sethi
- Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY, USA
| | - A A Patel
- Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY, USA
| | - A A Aadam
- Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - J R Triggs
- Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - A Bapaye
- Department of Digestive Diseases & Endoscopy, Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India
| | - S Dorwat
- Department of Digestive Diseases & Endoscopy, Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India
| | - P Benias
- Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Medical Center, Northwell Health System, New Hyde Park, NY, USA
| | - D M Chaves
- Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
| | - M Barret
- Gastroenterology Unit, Cochin University Hospital, Université Paris Descartes, Paris, France.,Unité INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - R J Law
- University of Michigan Health Care System, Ann Arbor, USA
| | - N Browers
- University of Michigan Health Care System, Ann Arbor, USA
| | - M Pioche
- Service d'Hépato-gastro-entérologie, Hôpital Edouard Herriot, CHU Lyon, Lyon, France
| | - P V Draganov
- Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, FL, USA
| | - A Kotzev
- Clinic of Gastroenterology, University Hospital "Alexandrovska", Sofia, Bulgaria
| | - F Estremera
- Clinic of Gastroenterology, University Hospital "Alexandrovska", Sofia, Bulgaria
| | - E Albeniz
- Division of Gastroenterology, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - M B Ujiki
- Section of Minimally Invasive Surgery, Department of Surgery, NorthShore University Health System, Evanston, IL, USA
| | - Z M Callahan
- Section of Minimally Invasive Surgery, Department of Surgery, NorthShore University Health System, Evanston, IL, USA
| | - M I Itani
- Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA
| | - O G Brewer
- Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA
| | - M A Khashab
- Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA. .,Division of Gastroenterology and Hepatology, Johns Hopkins Hospital, Sheikh Zayed Bldg, 1800 Orleans Street, Suite 7125G, Baltimore, MD, 21287, USA.
| |
Collapse
|
3
|
Ichkhanian Y, Vosoughi K, Aghaie Meybodi M, Jacques J, Sethi A, Patel AA, Aadam AA, Triggs JR, Bapaye A, Dorwat S, Benias P, Chaves DM, Barret M, Law RJ, Browers N, Pioche M, Draganov PV, Kotzev A, Estremera F, Albeniz E, Ujiki MB, Callahan ZM, Itani MI, Brewer OG, Khashab MA. Comprehensive Analysis of Adverse Events Associated with Gastric Peroral Endoscopic Myotomy: An International Multicenter Study. Surg Endosc 2020; 35:1755-1764. [DOI: 10.1007/s00464-020-07570-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Accepted: 04/15/2020] [Indexed: 02/08/2023]
|
4
|
Patel AA, Nicholson K, Goldman T. Ultrasound Guided Robotic Assisted Myomectomy. J Minim Invasive Gynecol 2019. [DOI: 10.1016/j.jmig.2019.09.726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
5
|
Patel AA, Nimaroff ML. 2920 A Retrospective Look at Gynecological Surgical Complications. J Minim Invasive Gynecol 2019. [DOI: 10.1016/j.jmig.2019.09.498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
6
|
Heywood I, Camilo F, Cotton WD, Yusef-Zadeh F, Abbott TD, Adam RM, Aldera MA, Bauermeister EF, Booth RS, Botha AG, Botha DH, Brederode LRS, Brits ZB, Buchner SJ, Burger JP, Chalmers JM, Cheetham T, de Villiers D, Dikgale-Mahlakoana MA, du Toit LJ, Esterhuyse SWP, Fanaroff BL, Foley AR, Fourie DJ, Gamatham RRG, Goedhart S, Gounden S, Hlakola MJ, Hoek CJ, Hokwana A, Horn DM, Horrell JMG, Hugo B, Isaacson AR, Jonas JL, Jordaan JDBL, Joubert AF, Józsa GIG, Julie RPM, Kapp FB, Kenyon JS, Kotzé PPA, Kriel H, Kusel TW, Lehmensiek R, Liebenberg D, Loots A, Lord RT, Lunsky BM, Macfarlane PS, Magnus LG, Magozore CM, Mahgoub O, Main JPL, Malan JA, Malgas RD, Manley JR, Maree MDJ, Merry B, Millenaar R, Mnyandu N, Moeng IPT, Monama TE, Mphego MC, New WS, Ngcebetsha B, Oozeer N, Otto AJ, Passmoor SS, Patel AA, Peens-Hough A, Perkins SJ, Ratcliffe SM, Renil R, Rust A, Salie S, Schwardt LC, Serylak M, Siebrits R, Sirothia SK, Smirnov OM, Sofeya L, Swart PS, Tasse C, Taylor DT, Theron IP, Thorat K, Tiplady AJ, Tshongweni S, van Balla TJ, van der Byl A, van der Merwe C, van Dyk CL, Van Rooyen R, Van Tonder V, Van Wyk R, Wallace BH, Welz MG, Williams LP. Inflation of 430-parsec bipolar radio bubbles in the Galactic Centre by an energetic event. Nature 2019; 573:235-237. [PMID: 31511683 DOI: 10.1038/s41586-019-1532-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Accepted: 06/28/2019] [Indexed: 11/09/2022]
Abstract
The Galactic Centre contains a supermassive black hole with a mass of four million Suns1 within an environment that differs markedly from that of the Galactic disk. Although the black hole is essentially quiescent in the broader context of active galactic nuclei, X-ray observations have provided evidence for energetic outbursts from its surroundings2. Also, although the levels of star formation in the Galactic Centre have been approximately constant over the past few hundred million years, there is evidence of increased short-duration bursts3, strongly influenced by the interaction of the black hole with the enhanced gas density present within the ring-like central molecular zone4 at Galactic longitude |l| < 0.7 degrees and latitude |b| < 0.2 degrees. The inner 200-parsec region is characterized by large amounts of warm molecular gas5, a high cosmic-ray ionization rate6, unusual gas chemistry, enhanced synchrotron emission7,8, and a multitude of radio-emitting magnetized filaments9, the origin of which has not been established. Here we report radio imaging that reveals a bipolar bubble structure, with an overall span of 1 degree by 3 degrees (140 parsecs × 430 parsecs), extending above and below the Galactic plane and apparently associated with the Galactic Centre. The structure is edge-brightened and bounded, with symmetry implying creation by an energetic event in the Galactic Centre. We estimate the age of the bubbles to be a few million years, with a total energy of 7 × 1052 ergs. We postulate that the progenitor event was a major contributor to the increased cosmic-ray density in the Galactic Centre, and is in turn the principal source of the relativistic particles required to power the synchrotron emission of the radio filaments within and in the vicinity of the bubble cavities.
Collapse
Affiliation(s)
- I Heywood
- Department of Physics, University of Oxford, Oxford, UK. .,Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa. .,South African Radio Astronomy Observatory, Cape Town, South Africa.
| | - F Camilo
- South African Radio Astronomy Observatory, Cape Town, South Africa.
| | - W D Cotton
- South African Radio Astronomy Observatory, Cape Town, South Africa.,National Radio Astronomy Observatory, Charlottesville, VA, USA
| | - F Yusef-Zadeh
- CIERA and Department of Physics and Astronomy, Northwestern University, Evanston, IL, USA
| | - T D Abbott
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R M Adam
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - M A Aldera
- Tellumat (Pty) Ltd, Retreat, South Africa
| | - E F Bauermeister
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R S Booth
- Chalmers University of Technology, Gothenburg, Sweden
| | - A G Botha
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - D H Botha
- EMSS Antennas (Pty) Ltd, Stellenbosch, South Africa
| | - L R S Brederode
- South African Radio Astronomy Observatory, Cape Town, South Africa.,SKA Organisation, Jodrell Bank, Macclesfield, UK
| | - Z B Brits
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S J Buchner
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J P Burger
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J M Chalmers
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - T Cheetham
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - D de Villiers
- Department of Electrical and Electronic Engineering, Stellenbosch University, Stellenbosch, South Africa
| | | | - L J du Toit
- EMSS Antennas (Pty) Ltd, Stellenbosch, South Africa
| | - S W P Esterhuyse
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - B L Fanaroff
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A R Foley
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - D J Fourie
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R R G Gamatham
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S Goedhart
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S Gounden
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - M J Hlakola
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - C J Hoek
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A Hokwana
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - D M Horn
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J M G Horrell
- IDIA, University of Cape Town, Rondebosch, South Africa
| | - B Hugo
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A R Isaacson
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J L Jonas
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J D B L Jordaan
- South African Radio Astronomy Observatory, Cape Town, South Africa.,EMSS Antennas (Pty) Ltd, Stellenbosch, South Africa
| | - A F Joubert
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - G I G Józsa
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R P M Julie
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - F B Kapp
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J S Kenyon
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa
| | - P P A Kotzé
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - H Kriel
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - T W Kusel
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R Lehmensiek
- EMSS Antennas (Pty) Ltd, Stellenbosch, South Africa.,Department of Electrical Engineering, Cape Peninsula University of Technology, Bellville, South Africa
| | - D Liebenberg
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A Loots
- Presidential Infrastructure Coordinating Commission, Pretoria, South Africa
| | - R T Lord
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - B M Lunsky
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - P S Macfarlane
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - L G Magnus
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - C M Magozore
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - O Mahgoub
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J P L Main
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J A Malan
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R D Malgas
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - J R Manley
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - M D J Maree
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - B Merry
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R Millenaar
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - N Mnyandu
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - I P T Moeng
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - T E Monama
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - M C Mphego
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - W S New
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - B Ngcebetsha
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,South African Radio Astronomy Observatory, Cape Town, South Africa
| | - N Oozeer
- South African Radio Astronomy Observatory, Cape Town, South Africa.,African Institute for Mathematical Sciences, Muizenberg, South Africa
| | - A J Otto
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S S Passmoor
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A A Patel
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A Peens-Hough
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S J Perkins
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S M Ratcliffe
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R Renil
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A Rust
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S Salie
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - L C Schwardt
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - M Serylak
- South African Radio Astronomy Observatory, Cape Town, South Africa.,Department of Physics and Astronomy, University of the Western Cape, Bellville, South Africa
| | - R Siebrits
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S K Sirothia
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,South African Radio Astronomy Observatory, Cape Town, South Africa
| | - O M Smirnov
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,South African Radio Astronomy Observatory, Cape Town, South Africa
| | - L Sofeya
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - P S Swart
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - C Tasse
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,GEPI, CNRS, PSL Research University, Meudon, France
| | - D T Taylor
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - I P Theron
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,EMSS Antennas (Pty) Ltd, Stellenbosch, South Africa
| | - K Thorat
- Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.,South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A J Tiplady
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - S Tshongweni
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - T J van Balla
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - A van der Byl
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - C van der Merwe
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - C L van Dyk
- Peralex Electronics (Pty) Ltd, Bergvliet, South Africa
| | - R Van Rooyen
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - V Van Tonder
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - R Van Wyk
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - B H Wallace
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - M G Welz
- South African Radio Astronomy Observatory, Cape Town, South Africa
| | - L P Williams
- South African Radio Astronomy Observatory, Cape Town, South Africa
| |
Collapse
|
7
|
Collard MD, Xi Y, Patel AA, Scott KM, Jones S, Chhabra A. Initial experience of CT-guided pulsed radiofrequency ablation of the pudendal nerve for chronic recalcitrant pelvic pain. Clin Radiol 2019; 74:897.e17-897.e23. [PMID: 31447049 DOI: 10.1016/j.crad.2019.06.028] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2018] [Accepted: 06/28/2019] [Indexed: 11/27/2022]
Abstract
AIM To evaluate initial experience with computed tomography (CT)-guided pulsed radiofrequency ablation (pRFA) of the pudendal nerve in cases of recalcitrant neuropathic pelvic pain. Endpoints include technical feasibility, safety, and efficacy of therapy. MATERIALS AND METHODS Ten patients who underwent pRFA ablation for neuropathic pudendal nerve pain during the trial period were followed for response to treatment for 6 months. Each patient was treated with pRFA under CT-guidance with concurrent perineural injection of anaesthetic and/or corticosteroid. Pain scores were then measured using a numeric rating scale at fixed intervals up to 6 months. RESULTS All procedures were considered technically successful with no immediate complications. pRFA demonstrated improved duration of pain improvement compared to the most recent perineural injection (p=0.0195), but not compared to the initial injection (p=0.64). Reported pain scores were lower with pRFA than with both the first and most recent injection but this did not reach statistical significance (p=0.1094 and p=0.7539, respectively). CONCLUSION Overall, pRFA of the pudendal nerve using CT-guidance can be a safe and effective therapy. This technique provides direct visualisation of the nerve to maximise safety and efficacy while offering a novel form of therapy for patients with chronic, recalcitrant pelvic pain.
Collapse
Affiliation(s)
- M D Collard
- Radiology Department, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
| | - Y Xi
- Radiology Department, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
| | - A A Patel
- Radiology Department, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
| | - K M Scott
- Physical Medicine and Rehabilitation Department, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
| | - S Jones
- Anesthesia and Pain Management Department, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
| | - A Chhabra
- Radiology Department, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA; Orthopedic Surgery Department, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA.
| |
Collapse
|
8
|
Popat A, Patel AA, Warnes G. A Flow Cytometric Study of ER Stress and Autophagy. Cytometry A 2018; 95:672-682. [PMID: 30451364 DOI: 10.1002/cyto.a.23665] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2018] [Revised: 08/09/2018] [Accepted: 10/08/2018] [Indexed: 01/18/2023]
Abstract
The mechanistic link between ER stress, autophagy, and resultant cell death was investigated by the use of drugs Thapsigargin (Tg) and Chloroquine (CQ) with prior induction and or blockade of autophagy and apoptosis which modulated the ER stress response and resultant form of cell death. All these biological processes can be measured flow cytometrically allowing the determination of the type of cell death, G1 cell cycle arrest, cell cycle dependent measurement of ER stress transducer PERK, misfolded proteins, reticulophagy, and autophagy marker LC3B. Jurkat cells after Tg or CQ treatment became necrotic and apoptotic, showed G1 cell cycle arrest, autophagy, and ER stress. Prior induction of autophagy before ER stress increased levels of necrotic and apoptotic cell death. Autophagy was further up-regulated, while PERK was reduced or abrogated. CQ showed reduced levels of misfolded proteins and reticulophagy, while Tg showed no change in misfolded protein levels but increased reticulophagy and thus displayed more ER stress. Prior blockade of apoptosis before induction of ER stress resulted in cell survival except with high Tg levels which induced necrosis. Autophagy was up-regulated with modulation of PERK and reticulophagy levels with an abrogation of the misfolded protein response. Blockade of apoptosis with induction of autophagy before ER stress showed death by necrosis with high dose drugs and cell survival with low doses of drugs. CQ induced reduced levels G1 cell cycle arrest while it was maintained with Tg. Autophagy was also maintained with reduced levels of ER stress. These data demonstrates a profound link between the processes of ER stress, autophagy, and the resultant form of cell death all of which can be modulated depending upon the sequence and concentration of drugs employed. © 2018 International Society for Advancement of Cytometry.
Collapse
Affiliation(s)
- A Popat
- Flow Cytometry Core Facility, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary London University, London, England
| | - A A Patel
- Flow Cytometry Core Facility, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary London University, London, England
| | - G Warnes
- Flow Cytometry Core Facility, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary London University, London, England
| |
Collapse
|
9
|
Abstract
Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer worldwide and in the United States. OSCC remains a major cause of morbidity and mortality in patients with head and neck cancers. Tobacco and alcohol consumption alone or with chewing betel nut are potential risk factors contributing to the high prevalence of OSCC. Multimodality therapies, including surgery, chemotherapy, biologic therapy, and radiotherapy, particularly intensity-modulated radiotherapy (IMRT), are the current treatments for OSCC patients. Despite recent advances in these treatment modalities, the overall survival remains poor over the past years. Recent data from whole-exome sequencing reveal that TP53 is commonly mutated in human papillomavirus-negative OSCC patients. Furthermore, these data stressed the importance of the TP53 gene in suppressing the development and progression of OSCC. Clinically, TP53 mutations are largely associated with poor survival and tumor resistance to radiotherapy and chemotherapy in OSCC patients, which makes the TP53 mutation status a potentially useful molecular marker prognostic and predictive of clinical response in these patients. Several forms of DNA damage have been shown to activate p53, including those generated by ionizing radiation and chemotherapy. The DNA damage stabilizes p53 in part via the DNA damage signaling pathway that involves sensor kinases, including ATM and ATR and effector kinases, such as Chk1/2 and Wee1, which leads to posttranscriptional regulation of a variety of genes involved in DNA repair, cell cycle control, apoptosis, and senescence. Here, we discuss the link of TP53 mutations with treatment outcome and survival in OSCC patients. We also provide evidence that small-molecule inhibitors of critical proteins that regulate DNA damage repair and replication stress during the cell cycle progression, as well as other molecules that restore wild-type p53 activity to mutant p53, can be exploited as novel therapeutic approaches for the treatment of OSCC patients bearing p53 mutant tumors.
Collapse
Affiliation(s)
- A Lindemann
- 1 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - H Takahashi
- 1 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - A A Patel
- 1 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - A A Osman
- 1 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - J N Myers
- 1 Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| |
Collapse
|
10
|
Arora SK, Patel AA. Effect of fiber blends, total solids, heat treatment, whey protein concentrate and stage of sugar incorporation on dietary fiber-fortified Kheer. J Food Sci Technol 2017; 54:3512-3520. [PMID: 29051646 DOI: 10.1007/s13197-017-2808-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Revised: 08/04/2017] [Accepted: 08/10/2017] [Indexed: 11/30/2022]
Abstract
Owing to the proven beneficial role of dietary fiber (DF) on human health, feasibility of incorporating commercially available soluble and insoluble DF preparations into rice-milk-pudding (kheer, a popular Indian delicacy) was studied through process modification. The novel approach of preparing reduced fat DF-fortified-kheer (DFFK) by developing liquid/cream phase and particulate/rice phase separately, and subsequently blending the two was developed. The major processing variables studied were total solids (TS) in the liquid phase, type of fiber blend, flavor-simulation through heat treatment or added whey protein, and the presence of sugar in water for pre-cooking of rice. Reduced fat DFFK made from three different pre-standardized fiber blends was quite acceptable to the sensory panel (overall rating 7.5). With increasing TS in milk up to 16.5%, sensory acceptability of DFFK increased. There was a small but perceivable improvement in the flavour of DFFK when precooking of rice was carried out in sweetened water. Reduced fat DFFK from different fiber blends was found to be reasonably close to conventional kheer. DFFK prepared from Blend-I provided 3.31 g dietary fiber/100 kcal (suitable for the claim "High-in-Fiber") with 38.71% Reduced-Fat. With the developed process of fortification of kheer with DF, it is possible to reduce fat (and thus calories) to cater to the needs of consumers seeking good health.
Collapse
Affiliation(s)
- Simran Kaur Arora
- Depatment of Food Science & Technology, G.B.P.U.A. & T., Pantnagar, US Nagar, India
| | - A A Patel
- National Dairy Research Institute, Karnal, India
| |
Collapse
|
11
|
Minhas SV, Mazmudar AS, Patel AA. Pre-operative functional status as a predictor of morbidity and mortality after elective cervical spine surgery. Bone Joint J 2017; 99-B:824-828. [DOI: 10.1302/0301-620x.99b6.bjj-2016-1149.r1] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Accepted: 02/02/2017] [Indexed: 11/05/2022]
Abstract
Aims Patients seeking cervical spine surgery are thought to be increasing in age, comorbidities and functional debilitation. The changing demographics of this population may significantly impact the outcomes of their care, specifically with regards to complications. In this study, our goals were to determine the rates of functionally dependent patients undergoing elective cervical spine procedures and to assess the effect of functional dependence on 30-day morbidity and mortality using a large, validated national cohort. Patients and Methods A retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program data files from 2006 to 2013 was conducted to identify patients undergoing common cervical spine procedures. Multivariate logistic regression models were generated to analyse the independent association of functional dependence with 30-day outcomes of interest. Results Patients with lower functional status had significantly higher rates of medical comorbidities. Even after accounting for these comorbidities, type of procedure and pre-operative diagnosis, analyses demonstrated that functional dependence was independently associated with significantly increased odds of sepsis (odds ratio (OR) 5.04), pulmonary (OR 4.61), renal (OR 3.33) and cardiac complications (OR 4.35) as well as mortality (OR 11.08). Conclusions Spine surgeons should be aware of the inherent risks of these procedures with the functionally dependent patient population when deciding on whether to perform cervical spine surgery, delivering pre-operative patient counselling, and providing peri-operative management and surveillance. Cite this article: Bone Joint J 2017;99-B:824–8.
Collapse
Affiliation(s)
- S. V. Minhas
- NYU Langone Hospital for Joint Diseases, Department
of Orthopaedic Surgery, New York, NY, USA
| | - A. S. Mazmudar
- Feinberg School of Medicine, Northwestern
University, Department of Orthopaedic Surgery, Chicago, IL, USA
| | - A. A. Patel
- Feinberg School of Medicine, Northwestern
University, Department of Orthopaedic Surgery, Chicago, IL, USA
| |
Collapse
|
12
|
Arora SK, Patel AA, Kumar N, Chauhan OP. Determination of relationship between sensory viscosity rating and instrumental flow behaviour of soluble dietary fibers. J Food Sci Technol 2016; 53:2067-76. [PMID: 27413236 DOI: 10.1007/s13197-016-2193-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Revised: 02/23/2016] [Accepted: 02/25/2016] [Indexed: 11/25/2022]
Abstract
The shear-thinning low, medium and high-viscosity fiber preparations (0.15-1.05 % psyllium husk, 0.07-0.6 % guar gum, 0.15-1.20 % gum tragacanth, 0.1-0.8 % gum karaya, 0.15-1.05 % high-viscosity Carboxy Methyl Cellulose and 0.1-0.7 % xanthan gum) showed that the consistency coefficient (k) was a function of concentration, the relationship being exponential (R(2), 0.87-0.96; P < 0.01). The flow behaviour index (n) (except for gum karaya and CMC) was exponentially related to concentration (R(2), 0.61-0.98). The relationship between k and sensory viscosity rating (SVR) was essentially linear in nearly all cases. The SVR could be predicted from the consistency coefficient using the regression equations developed. Also, the relationship of k with fiber concentration would make it possible to identify the concentration of a particular gum required to have desired consistency in terms of SVR.
Collapse
Affiliation(s)
| | - A A Patel
- National Dairy Research Institute, Karnal, India
| | | | - O P Chauhan
- Defence Food Research Laboratories, Mysore, India
| |
Collapse
|
13
|
Maka VV, Pancha H, Shukla SN, Talati SS, Shah PM, Patel KM, Anand AS, Shah SA, Patel AA, Parikh S. Clinical Characteristics and prognostic analysis of Triple-negative Breast Cancer: Single institute experience. Gulf J Oncolog 2016; 1:38-44. [PMID: 27050178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/30/2015] [Indexed: 06/05/2023]
Abstract
BACKGROUND Triple-negative breast cancer (TNBC) is a poor prognostic subset of breast cancer that lacks the benefit of specific targeted therapy. MATERIALS AND METHODS A prospective study of the clinical profile of triple negative breast cancer cases at a tertiary referral centre. The duration of the study period was 26 months and the median follow up period was ten months. A total of 111 invasive breast cancer patients were evaluated from 1st August 2009 to 31st October 2011. We examined TNBC patients with respect to clinicopathological parameters, adjuvant chemotherapy regimens and relapse free survival. RESULTS In our study, patients were young (median age at presentation, 47yrs), premenopausal (54%), tumour size was discordant with lymph node positivity, the histology was predominantly intraductal carcinoma (90%), histological grade higher than two (90%). Relapses were early and preferential visceral (32%) and CNS metastasises (11.7%). 91% of patients were eligible for adjuvant therapy but only 80% of the patients could complete full course of adjuvant chemotherapy. Anthracycline-based regimens (43%), sequential anthracycline and taxane-based regimen (24%) and other regimes like CMF (13%) were used as adjuvant chemotherapy in eligible TNBC patients. Median relapse free survival in patients following adjuvant chemotherapy was around 10 months at last follow-up. CONCLUSIONS Patients with TNBC have aggressive clinicopathological characteristics with early and higher rate of disease relapse and therefore derive inadequate benefit from current adjuvant chemotherapy. So, new treatment strategies in adjuvant chemotherapy for TNBC are needed.
Collapse
Affiliation(s)
- V V Maka
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - H Pancha
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - S N Shukla
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - S S Talati
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - P M Shah
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - K M Patel
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - A S Anand
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - S A Shah
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - A A Patel
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| | - S Parikh
- Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
| |
Collapse
|
14
|
Jha A, Patel AA, Gopal TKS, Ravishankar CN. Heat penetration characteristics and physico-chemical properties of in-pouch processed dairy dessert (kheer). J Food Sci Technol 2014; 51:2560-7. [PMID: 25328196 DOI: 10.1007/s13197-012-0750-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Revised: 05/25/2012] [Accepted: 05/29/2012] [Indexed: 11/25/2022]
Abstract
Kheer, a traditional milk product of South East Asia, containing cooked rice grains in a creamy sweetened concentrated milk, has no large-scale production due to its poor shelf life. Shelf-life was improved by development of a process based on in-pouch thermal processing employing a rotary retort. Product development included optimization of rice-to-milk solids ratio (0.18-0.52) and total milk solids levels (16-26 %) to simulate the conventional product in taste, appearance and textural attributes. Various Fo values (12.4-14.8) were examined with regard to product quality. While the TBA value tended to increase (0.073-0.081) the reflectance value (35.3-43.4) declined with increasing Fo. The pH of the product (6.04-6.10) showed a slight tendency to increase with Fo. Sensorily, the product was found to be acceptable for a period of 150 days at 37 °C.
Collapse
Affiliation(s)
- Alok Jha
- Department of A. H. & Dairying, Banaras Hindu University, Varanasi, 221 005 India
| | - A A Patel
- Dairy Technology Division, National Dairy Research Institute, Karnal, 132 001 India
| | | | - C N Ravishankar
- Central Institute of Fisheries Technology, Kochi, 682 029 India
| |
Collapse
|
15
|
Ponomarenko LA, Gorbachev RV, Yu GL, Elias DC, Jalil R, Patel AA, Mishchenko A, Mayorov AS, Woods CR, Wallbank JR, Mucha-Kruczynski M, Piot BA, Potemski M, Grigorieva IV, Novoselov KS, Guinea F, Fal'ko VI, Geim AK. Cloning of Dirac fermions in graphene superlattices. Nature 2013; 497:594-7. [PMID: 23676678 DOI: 10.1038/nature12187] [Citation(s) in RCA: 429] [Impact Index Per Article: 39.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2012] [Accepted: 04/03/2013] [Indexed: 11/09/2022]
Abstract
Superlattices have attracted great interest because their use may make it possible to modify the spectra of two-dimensional electron systems and, ultimately, create materials with tailored electronic properties. In previous studies (see, for example, refs 1-8), it proved difficult to realize superlattices with short periodicities and weak disorder, and most of their observed features could be explained in terms of cyclotron orbits commensurate with the superlattice. Evidence for the formation of superlattice minibands (forming a fractal spectrum known as Hofstadter's butterfly) has been limited to the observation of new low-field oscillations and an internal structure within Landau levels. Here we report transport properties of graphene placed on a boron nitride substrate and accurately aligned along its crystallographic directions. The substrate's moiré potential acts as a superlattice and leads to profound changes in the graphene's electronic spectrum. Second-generation Dirac points appear as pronounced peaks in resistivity, accompanied by reversal of the Hall effect. The latter indicates that the effective sign of the charge carriers changes within graphene's conduction and valence bands. Strong magnetic fields lead to Zak-type cloning of the third generation of Dirac points, which are observed as numerous neutrality points in fields where a unit fraction of the flux quantum pierces the superlattice unit cell. Graphene superlattices such as this one provide a way of studying the rich physics expected in incommensurable quantum systems and illustrate the possibility of controllably modifying the electronic spectra of two-dimensional atomic crystals by varying their crystallographic alignment within van der Waals heterostuctures.
Collapse
Affiliation(s)
- L A Ponomarenko
- School of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Webster TJ, Patel AA, Rahaman MN, Sonny Bal B. Anti-infective and osteointegration properties of silicon nitride, poly(ether ether ketone), and titanium implants. Acta Biomater 2012; 8:4447-54. [PMID: 22863905 DOI: 10.1016/j.actbio.2012.07.038] [Citation(s) in RCA: 117] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2012] [Revised: 07/19/2012] [Accepted: 07/25/2012] [Indexed: 11/17/2022]
Abstract
Silicon nitride (Si(3)N(4)) is an industrial ceramic used in spinal fusion and maxillofacial reconstruction. Maximizing bone formation and minimizing bacterial infection are desirable attributes in orthopedic implants designed to adhere to living bone. This study has compared these attributes of Si(3)N(4) implants with implants made from two other orthopedic biomaterials, i.e. poly(ether ether ketone) (PEEK) and titanium (Ti). Dense implants made of Si(3)N(4), PEEK, or Ti were surgically implanted into matching rat calvarial defects. Bacterial infection was induced with an injection of 1×10(4)Staphylococcus epidermidis. Control animals received saline only. On 3, 7, and 14days, and 3months post-surgery four rats per time period and material were killed, and calvariae were examined to quantify new bone formation and the presence or absence of bacteria. Quantitative evaluation of osteointegration to adjacent bone was done by measuring the resistance to implant push-out (n=8 rats each for Ti and PEEK, and n=16 rats for Si(3)N(4)). Three months after surgery in the absence of bacterial injection new bone formation around Si(3)N(4) was ∼69%, compared with 24% and 36% for PEEK and Ti, respectively. In the presence of bacteria new bone formation for Si(3)N(4), Ti, and PEEK was 41%, 26%, and 21%, respectively. Live bacteria were identified around PEEK (88%) and Ti (21%) implants, whereas none were present adjacent to Si(3)N(4). Push-out strength testing demonstrated statistically superior bone growth onto Si(3)N(4) compared with Ti and PEEK. Si(3)N(4) bioceramic implants demonstrated superior new bone formation and resistance to bacterial infection compared with Ti and PEEK.
Collapse
Affiliation(s)
- T J Webster
- School of Engineering and Department of Orthopaedics, Brown University, Providence, RI 02917, USA
| | | | | | | |
Collapse
|
17
|
Abstract
Study design: Retrospective clinical study of patients treated for subaxial cervical spine trauma (SCST) at a tertiary medical center. Purpose: Evaluate the validity of the Subaxial Injury Classification (SLIC) system in surgical versus non-surgical decision making for SCST. Inclusion criteria: Age >12 years, presence of SCST with complete clinical and radiological (CT and MRI) data. Exclusion criteria: Patients with incomplete radiographic or clinical data, pathological fractures, isolated upper cervical trauma (occiput to C2), isolated transverse process or spinous process fractures, chronic or age indeterminate fractures, isolate MRI findings, and severe systemic trauma with death prior to either surgical or non-surgical treatment. Results: Fourteen patients were treated non-surgically (C), whereas 24 were treated surgically (S). In the C group, the SLIC score ranged from 0 to 5 points (standard deviation [SD] = 1.20 points; mean 1.07; median 1). Just 1 patient had an SLIC score greater than 2 (7.1% of the patients). In the S group, the SLIC score ranged from 1 to 10 points (standard deviation [SD] = 2.03 points; mean 5.6; median 6). Just 2 patients had an SLIC score smaller than 4 (both with 1 point each, 8.3% of the total group). All the other 22 (accounting for 91.6%) patients had an SLIC of 4 or more points. Conclusions: Our study suggests that the SLIC classification looks to be a promising system to aid spinal surgeons in the decision-making process of subaxial cervical trauma, but a large prospective cohort study is required.
Collapse
Affiliation(s)
- A F Joaquim
- Department of Neurology, Neurosurgery Division, State University of Campinas, Campinas-SP, Brazil
| | | | | | | | | |
Collapse
|
18
|
Sandrasegaran K, Patel AA, Ramaswamy R, Samuel VP, Northcutt BG, Frank MS, Francis IR. Characterization of adrenal masses with diffusion-weighted imaging. Int Braz J Urol 2011. [DOI: 10.1590/s1677-55382011000600020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
| | - AA Patel
- Indiana University School of Medicine
| | | | - VP Samuel
- Indiana University School of Medicine
| | | | - MS Frank
- Indiana University School of Medicine
| | | |
Collapse
|
19
|
Sandrasegaran K, Akisik FM, Patel AA, Rydberg M, Cramer HM, Agaram NP, Schmidt CM. Diffusion-weighted imaging in characterization of cystic pancreatic lesions. Clin Radiol 2011; 66:808-14. [PMID: 21601184 DOI: 10.1016/j.crad.2011.01.016] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2010] [Accepted: 01/10/2011] [Indexed: 12/19/2022]
Abstract
AIM To evaluate whether apparent diffusion coefficient (ADC) measurements from diffusion-weighted imaging (DWI) can characterize or predict the malignant potential of cystic pancreatic lesions. MATERIALS AND METHODS Retrospective review of the magnetic resonance imaging (MRI) database over a 2-year period revealed 136 patients with cystic pancreatic lesions. Patients with DWI studies and histological confirmation of cystic mass were included. In patients with known pancreatitis, lesions with amylase content of >1000 IU/l that resolved on subsequent scans were included as pseudocysts. ADC of cystic lesions was measured by two independent reviewers. These values were then compared to categorize these lesions as benign or malignant using conventional MRI sequences. RESULTS Seventy lesions were analysed: adenocarcinoma (n=4), intraductal papillary mucinous neoplasm (IPMN; n=28), mucinous cystic neoplasm (MCN; n=9), serous cystadenoma (n=16), and pseudocysts (n=13). There was no difference between ADC values of malignant and non-malignant lesions (p=0.06), between mucinous and serous tumours (p=0.12), or between IPMN and MCN (p=0.42). ADC values for low-grade IPMN were significantly higher than those for high-grade or invasive IPMN (p=0.03). CONCLUSION ADC values may be helpful in deciding the malignant potential of IPMN. However, they are not useful in differentiating malignant from benign lesions or for characterizing cystic pancreatic lesions.
Collapse
Affiliation(s)
- K Sandrasegaran
- Department of Radiology, Indiana University School of Medicine, Indianapolis, IN, USA.
| | | | | | | | | | | | | |
Collapse
|
20
|
Sureshkumar KK, Patel AA, Arora S, Marcus RJ. When is it reasonable to split pediatric en bloc kidneys for transplantation into two adults? Transplant Proc 2011; 42:3521-3. [PMID: 21094808 DOI: 10.1016/j.transproceed.2010.08.038] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2010] [Revised: 07/09/2010] [Accepted: 08/19/2010] [Indexed: 12/14/2022]
Abstract
BACKGROUND Traditionally, kidneys from donors ≥60 years old and pediatric kidneys are considered marginal organs for transplantation. Pediatric donor kidneys are underutilized for transplantation into adult recipients due to concern for poor outcomes. METHODS Using data from the Organ Procurement and Transplant Network, we analyzed patterns of pediatric kidney use (single vs en bloc) in the United States from 1987 to 2007. Using the Cox proportional hazards model, graft outcomes of pediatric donor kidneys transplanted as single vs en bloc grafts from different donor weight groups were compared with renal transplantation from donors ≥60 years old in an attempt to define a pediatric donor weight at which kidneys can be justifiably split to expand the donor pool. RESULTS Compared with older donor kidneys, graft failure risk of pediatric single kidneys was consistently lower when the donor weight exceeded 10 kg. On the other hand, graft survival benefit for pediatric en bloc kidneys was evident starting at donor weight ≤10 kg in comparison to older donor kidneys. Pediatric en bloc kidneys performed consistently better than pediatric single kidneys for all donor weight groups. CONCLUSIONS Splitting of pediatric donor en bloc kidneys for transplantation into 2 adults when the donor weight exceeds 10 kg was associated with acceptable graft outcomes. This practice, along with increased use of small pediatric donor kidneys, may help to alleviate the waiting list burden in renal transplantation.
Collapse
Affiliation(s)
- K K Sureshkumar
- Division of Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh PA 15212, USA.
| | | | | | | |
Collapse
|
21
|
Kim TH, Zollinger L, Shi XF, Kim SE, Rose J, Patel AA, Jeong EK. Quantification of diffusivities of the human cervical spinal cord using a 2D single-shot interleaved multisection inner volume diffusion-weighted echo-planar imaging technique. AJNR Am J Neuroradiol 2010; 31:682-7. [PMID: 20019109 DOI: 10.3174/ajnr.a1881] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
BACKGROUND AND PURPOSE DTI is a highly sensitive technique, which can detect pathology not otherwise noted with conventional imaging methods. This paper provides the atlas of reliable normative in vivo DTI parameters in the cervical spinal cord and its potential applications toward quantifying pathology. MATERIALS AND METHODS In our study, we created a reference of normal diffusivities of the cervical spinal cord by using a 2D ss-IMIV-DWEPI technique from 14 healthy volunteers and compared parameters with those in 8 patients with CSM. The 2D ss-IMIV-DWEPI technique was applied in each subject to acquire diffusion-weighted images. FA, lambda( parallel), and lambda( perpendicular) were calculated. A reference of normal DTI indices from 12 regions of interest was created and compared with DTI indices of 8 patients. RESULTS A map of reference diffusivity values was obtained from healthy controls. We found statistically significant differences in diffusivities between healthy volunteers and patients with CSM with different severities of disease, by using FA, lambda( parallel), and lambda( perpendicular) values. CONCLUSIONS DTI using 2D ss-IMIV-DWPEI is sensitive to spinal cord pathology. This technique can be used to detect and quantify the degree of pathology within the cervical spinal cord from multiple disease states.
Collapse
Affiliation(s)
- T H Kim
- Department of Radiology, Utah Center for Advanced Imaging Research, University of Utah, Salt Lake City, 84108-1218, USA
| | | | | | | | | | | | | |
Collapse
|
22
|
Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52:2288-98. [PMID: 19655124 DOI: 10.1007/s00125-009-1470-0] [Citation(s) in RCA: 864] [Impact Index Per Article: 57.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2009] [Accepted: 06/19/2009] [Indexed: 01/12/2023]
Abstract
AIMS/HYPOTHESIS Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, compared with less-intensive, glucose control on the risk of major cardiovascular events amongst patients with type 2 diabetes. METHODS A prospectively planned group-level meta-analysis in which characteristics of trials to be included, outcomes of interest, analyses and subgroup definitions were all pre-specified. RESULTS A total of 27,049 participants and 2,370 major vascular events contributed to the meta-analyses. Allocation to more-intensive, compared with less-intensive, glucose control reduced the risk of major cardiovascular events by 9% (HR 0.91, 95% CI 0.84-0.99), primarily because of a 15% reduced risk of myocardial infarction (HR 0.85, 95% CI 0.76-0.94). Mortality was not decreased, with non-significant HRs of 1.04 for all-cause mortality (95% CI 0.90-1.20) and 1.10 for cardiovascular death (95% CI 0.84-1.42). Intensively treated participants had significantly more major hypoglycaemic events (HR 2.48, 95% CI 1.91-3.21). Exploratory subgroup analyses suggested the possibility of a differential effect for major cardiovascular events in participants with and without macrovascular disease (HR 1.00, 95% CI 0.89-1.13, vs HR 0.84, 95% CI 0.74-0.94, respectively; interaction p = 0.04). CONCLUSIONS/INTERPRETATION Targeting more-intensive glucose lowering modestly reduced major macrovascular events and increased major hypoglycaemia over 4.4 years in persons with type 2 diabetes. The analyses suggest that glucose-lowering regimens should be tailored to the individual.
Collapse
Affiliation(s)
-
- The George Institute for International Health, University of Sydney, Sydney, NSW 2050, Australia.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Int J Clin Pract 2009; 63:613-23. [PMID: 19222614 DOI: 10.1111/j.1742-1241.2009.02027.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND To perform a meta analysis of randomised placebo-controlled trials evaluating the use of dopamine agonist (DA) or placebo to preexisting levodopa therapy for the treatment of advanced Parkinson's disease (PD). We focused on clinically important efficacy [Unified Parkinson's Disease Rating Scale (UPDRS) activities of daily living (ADL) and motor scores as well as change in 'off' time and levodopa dose] and safety outcomes (withdrawal because of adverse drug events (ADEs), dyskinesias, hallucinations and mortality). METHODS A systematic literature search was performed between January 1990 and July 2007. The primary outcome measures assessed were the reduction in scores of Unified Parkinson's Disease Rating Scale (UPDRS) activities of daily living (ADL) and motor scores as well as reduction in 'off' time and reductions in levodopa dose from baseline. Safety end-points were also evaluated. RESULTS A total of 15 trials (n = 4380 subjects) were included in the meta analysis. Adjunctive DA use resulted in greater improvement as measured by the UPDRS ADL [weighted mean difference (WMD) -2.20, 95% confidence interval (CI) -2.64 to -1.76; p < 0.0001] and motor score reduction (WMD -5.56, 95% CI -6.82 to -4.31; p < 0.0001) as well as reduction in 'off' time measured in hours/day (WMD -1.20, 95% CI -1.78 to -0.62; p < 0.0001) and reduction in levodopa dose (WMD -128.5 mg, 95% CI -175.0 to -82.1; p < 0.0001) vs. placebo. Incidence of dyskinesia and hallucinations was higher with DAs [odds ratio (OR) 3.27, 95% CI 2.65-4.03; p < 0.0001] and (OR 3.34, 95% CI 2.44-4.58; p < 0.0001). Non-ergot DAs were qualitatively better, although both ergot and non-ergot DAs showed statistically significant improvements in all UPDRS scores. CONCLUSION Adjunctive DA use to levodopa is superior to levodopa alone in reducing PD symptoms in patients not controlled with monotherapy. DAs seem especially useful amongst PD patients with wearing-off phenomenon from levodopa therapy, but can cause some adverse events.
Collapse
Affiliation(s)
- R Talati
- University of Connecticut School of Pharmacy, Storrs, CT, USA
| | | | | | | | | |
Collapse
|
24
|
Torres K, Patel AA, Styliński K, Błoński M, Torres A, Staśkiewicz G, Maciejewski R, Wojtaszek M. The body constitution of patients and intubation scales as predictors of difficult intubation considered in relation to the experience of the intubator. Folia Morphol (Warsz) 2008; 67:171-174. [PMID: 18828097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The aims of the study were to identify factors that may result in difficulties in intubation, and to compare the results obtained when an experienced and when a less experienced anaesthesiologist was involved. The 96 patients included in the study were evaluated for difficult intubation according to the following scales: Mallampati, upper lip bite test (ULBT) and Patil. The mobility of the cervical segments of the vertebral column, the distance between the jugular notch of the sternum and the chin and the anatomical constitution of the body were other factors that were taken into consideration. Statistical analysis was performed in order to identify factors that may result in difficulties in intubation for an experienced and for a less experienced anaesthesiologist.
Collapse
Affiliation(s)
- K Torres
- Department of Human Anatomy, Medical University, Lublin, Poland.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Perkovic V, Cass A, Patel AA, Suriyawongpaisal P, Barzi F, Chadban S, Macmahon S, Neal B. High prevalence of chronic kidney disease in Thailand. Kidney Int 2007; 73:473-9. [PMID: 18059458 DOI: 10.1038/sj.ki.5002701] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We describe the prevalence of stage III and IV chronic kidney disease in Thailand from a representative sample of individuals aged 35 years and above using a stratified, multistage, cluster-sampling method. Population estimates were calculated by applying sampling weights from the 2000 Thai census. Glomerular filtration rates were estimated from serum creatinine using the Cockroft-Gault and the simplified Modification of Diet in Renal Disease (MDRD) formulae. The prevalence of stage III disease among individuals aged 35 years and above was estimated to be about 20% using the Cockroft-Gault formula and about 13% from the MDRD formula. Stage IV disease was present in about 0.9 and 0.6% of this population using the respective formulae. The highest prevalence rates were observed in less well-developed rural areas and the lowest in developed urban areas. The prevalence of chronic kidney disease was significantly higher than that reported in individuals over 40 years old from the United States for both stage III and IV disease and higher than the reported incidence in Taiwan and Australia. This high prevalence of chronic kidney disease in Thailand has obvious implications for the health of its citizens and for the allocation of health-care resources.
Collapse
Affiliation(s)
- V Perkovic
- George Institute for International Health, University of Sydney, Sydney, New South Wales, Australia.
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Patel AA, Patel KM, Shah SA, Shah PM, Shukla SN, Parikh BJ, Anand AS, Talati SS, Srivastav RK, Kattimani KA. Three years experience of infantile Wilms tumour at a single institute in a developing country. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.20028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
20028 Background: Wilms tumor (nephroblastoma) is the second most common malignant retroperitoneal tumor. It is the most common primary renal tumour of childhood and is a paradigm for multimodal treatment of a pediatric malignant solid tumor. The median age at diagnosis is 4 years and it is uncommon in infancy. We present a three year retrospective analysis of Wilms tumor in infants treated at out institute. Methods: A total of 16 cases of Wilms tumor were diagnosed in pediatric patients aged one and below between January 2003 to December 2005. Out of these, 11 patients were evaluable. All of them were given treatment as per the National Wilms Tumor Study- 5 protocol. Results: The median age of presentation was 10.8 months, one child was 5 months old rest all were between 10 and 12 months. The male to female ratio was 2.3:1. The most common presenting complaint was mass per abdomen, which was seen in 10 patients, one patient presented with pain in abdomen and hematuria. None of the patients had evidence of any other systemic involvement. 7 patients were in Stage I, 2 each were in stage II and stage III. Triphasic classical type (favorable) was the histopathological subtype in 9 patients and 2 had unfavorable histopathological subtypes. All the 10 cases underwent total Nephrectomy [three at our institute and the rest elsewhere] of the diseased kidney followed by treatment as per the National Wilms Tumor Study- 5 protocol with 50% dose reduction. 7 cases (70%) showed complete remission and presently are under observation. Three cases were lost to follow up after surgery. One patient with stage three disease was given anterior chemotherapy but was lost to follow up after 9 weeks of chemotherapy. Conclusion: Wilms tumor presenting in infancy when treated appropriately has a good outcome although not as good as in older children. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- A. A. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - K. M. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. A. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - P. M. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. N. Shukla
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - B. J. Parikh
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. S. Anand
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. S. Talati
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | | | | |
Collapse
|
27
|
Patel KM, Shah SA, Patel AA, Shah PM, Shukla SN, Parikh BJ, Anand AS, Talati SS, Srivastav RK, Dave RI. Results of cisplatin-based chemotherapy in inoperable hepatoblastoma during last two years at a single institute. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.20027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
20027 Background: Total surgical excision and adjunctive chemotherapy are cornerstones of treatment of hepatoblastoma in children. But many are unsuitable for radical surgery at diagnosis due to extensive intrahepatic and/or extra hepatic disease. We assessed 18 consecutive cases during the last two years, all of whom presented with unresectable tumor, treated in our center with neoadjuvant chemotherapy,in order to analyze the clinical profile and response to treatment. Methods: A retrospective analysis of patients who presented to our institute during January 2004 to January 2006 was carried out. All patients were biopsy proven hepatoblastoma. One patient was operated without anterior chemotherapy outside our institute .Two patients had lung metastasis. Rest all had stage 3 disease. All the patients were given cisplatin [90 mg/m2] and continuous infusion doxorubicin [80 mg/m2 over 4 days]. The response to therapy was assessed. Results: Mean age of presentation was 3 years and 4 months [range 1 year to 11 year]. M:F ratio was 4:1. Most common presenting complaint was an asymptomatic abdominal mass felt by the parent. All the patients had tumour in right lobe. Mean alpha fetoprotein level was 0.14 million and the range was from normal to 1.24 million. None of the patients were positive for hepatits B or hepatitis C. After three cycles of chemotherapy, seven of the seventeen patients had adequate down staging of the disease so as to undergo successful resection. There was one post operative mortality. All of them completed total of six cycles of chemotherapy. Ten patients had unresectable tumour even after six cycles of chemotherapy. All of them had reduction in the size of primary tumor and decreased alpha fetoprotein level .There was no chemotherapy related grade 3 or grade 4 toxicity. Conclusions: Hepatoblastoma occurs at a later age in Indian patients as compared to that seen in western countries. Cisplatin and adriamycin are quite effective in downstaging hepatoblastoma. Since these agents are cheap and have minimal toxicity they should be used frequently. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- K. M. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. A. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. A. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - P. M. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. N. Shukla
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - B. J. Parikh
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. S. Anand
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. S. Talati
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | | | - R. I. Dave
- Gujarat Cancer and Research Institute, Ahmedabad, India
| |
Collapse
|
28
|
Parikh AP SK, Shukla SN, Shah PM, Patel KM, Parikh BJ, Addl ASA, Asso SST, Shah SA, Panchal HP, Patel AA. Imatinib mesylate in the treatment of paediatric chronic myeloid leukaemia (CML): A study of 30 cases from a regional cancer centre in western India. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.20021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
20021 Background: CML is a very rare disease in childhood. There are scant data available concerning the use of Imatinib in the paediatric patients. Methods: Thirty cases of paediatric CML (25 males, 5 females; median age-11, range: 4–14 years, 23 Interferon naive, 1 interferon resistant) during the period of September 2003 to October 2006 were analyzed. Results: There were 28 patients in chronic phase (CP), 1 accelerated phase (AP) and 1 with blast crisis (BC). All patients were Philadelphia positive (Ph+) (20 by G-banding, 10 by fluorescence in situ hybridization [FISH]) and treated with imatinib using 260 mg/m2 daily for CP and 340 mg/m2 for AP/BC. The median time from diagnosis to imatinib therapy was 4 months (range: 0.5–91 months). Twenty-five (92.5%) of 27 evaluable patients achieved complete haematological remission (CHR) (World literature 95% in adult) at a median duration of 60 days (range: 25–150 days). Two patients did not respond; one of them with BC died due to progressive disease and three patients were not evaluable (2 patients loss to follow up and in 1 patient imatinib started recently). Complete cytogenetic response (CyGR) was achieved in 7 of 15 patients studied; 2 patients had partial CyGR while 4 had no CyGR while in 2 patients result was inconclusive. In 2 patients molecular remission was studied with RT-PCR, had attained it at 12 months. Overall, the drug was well tolerated and none of the patients had to permanently discontinue the drug. There were no treatment related deaths. The common adverse events were thrombocytopenia (6.6%), neutropenia (16.6%), skin rash (6.6%), anaemia (3.3%), superficial oedema (6.6%), weight gain (6.6%) and muscle cramps (3.3%). Severe (grade III-IV) events were infrequent except 1 patient with grade IV febrile neutropenia. At median follow up of 24 months (range: 1–35 months, 11 patients followed >24 months), one patient has haematological relapse while one patient has disease progression in form of myeloblastic crisis. Conclusions: The Imatinib mesylate treatment is safe and it achieves rapid and higher CHR in paediatric CML. No significant financial relationships to disclose.
Collapse
Affiliation(s)
| | - S. N. Shukla
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - P. M. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - K. M. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - B. J. Parikh
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | | | | | - S. A. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - H. P. Panchal
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. A. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| |
Collapse
|
29
|
Shah S, Patel KM, Patel AA, Shah PM, Shukla SN, Parikh BJ, Anand AS, Talati SS, Srivastav RK, Dave RI. Results of BFM 90 protocol at a single institute in a developing country: Three years experience. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.17524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
17524 Background: In a developing country the affordability status of a patient is the main factor in deciding the type of treatment a patient will receive. Majority of patients [>95%] at our institute have received MCP 841 protocol for acute lymphoblastic lymphoma .We have reviewed the treatment results of patients who had received chemotherapy as per the BFM 90 protocol over last 3 years. Methods: 18 patients (15 males and 3 females) with ALL who had received BFM 90 protocol as therapy during the period between January 2003 to January 2006 were analysed. 15 were of the pediatric age group (2–13 years) and 3 were adult patients (31 & 42 years). Median follow up period was 1 year 9 months. 5 patients were considered as high risk, 4 medium risk and the rest as standard risk. All patients were ph chromosome negative. Results: All paediatric patients are in CR. One patient had CNS relapse but he responded well to reinduction and is in CR. Three patients developed grade 4 toxicity after high dose methotrexate. The rest tolerated it well, however, leucoverin rescue had to be given empirically as methotrxeate level measurement was not available at that time. Two patients turned HCV positive during the course of treatment and had altered liver enzymes due to which maintenance treatment was interrupted. There were three instances of catheter removal and one port had to be removed due to infection. Both the adult patients had bone marrow relapse during treatment [one during maintenance and the other during reinduction] and could not be salvaged. Conclusions: BFM 90 protocol is a viable alternative to MCP 841 in developing countries where high dose methotrexate is given with empirical leucoverin rescue. High rates of catheter infection is of concern. Better patient education and improved techniques will probably improve the situation. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- S. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - K. M. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. A. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - P. M. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. N. Shukla
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - B. J. Parikh
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. S. Anand
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. S. Talati
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | | | - R. I. Dave
- Gujarat Cancer and Research Institute, Ahmedabad, India
| |
Collapse
|
30
|
Abstract
OBJECTIVE Family and personal history of colorectal cancer and associated tumours are crucial in identifying families with hereditary nonpolyposis colorectal cancer (HNPCC). The aim of this study was to determine the adequacy of these aspects of history-taking in the management of colorectal cancer patients. PATIENTS AND METHODS Colorectal cancer patients attending outpatient follow-up were interviewed to obtain a detailed family and personal history of cancers. The medical notes were then reviewed to identify whether these had been documented previously. RESULTS One hundred and one patients took part. In seven, no family history had been recorded; none of these actually had a significant pedigree. In 88, the family history was not significant, a finding correctly documented in the records. Three had a high-risk family history and another three had a personal history of other possible HNPCC-related cancers. In each of these patients, the relevant findings had been documented, but no further action had been taken. CONCLUSIONS Family history was taken in the majority of patients, but in the only three with a pedigree indicative of HNPCC, its significance was not appreciated. The potential relevance of multiple HNPCC-related cancers in the same individual was also overlooked. Improved education and referral pathways are needed to ensure that families with HNPCC have access to appropriate surveillance and genetic testing.
Collapse
Affiliation(s)
- V O Alberto
- Centre for Academic Surgery, Barts and the London, Queen Mary's School of Medicine and Dentistry, London University, London, UK
| | | | | | | |
Collapse
|
31
|
Patel AA, Shah PM, Patel KM, Shukla SN, Parikh BJ, Anand AS, Shah SA, Talati SS, Panchal HP, Pandey R. Childhood nasopharyngeal carcinoma: A 4-year single institution experience. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.9069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
9069 Background: Pediatric nasopharyngeal carcinoma (PNC) represents a locally advanced undifferentiated tumor. In this study, clinical experience and therapeutic results of 24 children with newly diagnosed PNC, treated in a single oncology institution in India over a period of 5 years, are analyzed. Methods: 24 patients (23 males and 1 female) 7–14 years old (median = 12) from Jan 2000 to Sep 2005 with PNC were retrospectively evaluated. 18/24 patients were evaluable. 16 patients received induction chemotherapy followed by radiotherapy while 1 patient was offered concurrent chemoradiotherapy, 1 patient received radiotherapy alone. 15/16 patients received postradiation chemotherapy. The agents used in induction and adjuvant therapy were cisplatin (100 mg/m2) on day 1 and 5-fluorouracil 750 mg/m2 for 5 days. The dose of radiotherapy used was 60 gray in 30 fractions. Results: The time of onset of symptoms to diagnosis ranged from 1 month to 9 months with a median of 5.5 months. Histopathology was lymphoepithelioma in 5 patients (27.7%) while 13 patients (72.2%) had poorly differentiated carcinoma. Disease extent was T2 (n = 7), T3 (n = 6), and T4 (n = 5); N1 (n = 5), N2 (n = 7), and N3 (n = 5). 7 patients had intracranial invasion. None had metastatic disease on presentation. 13 patients (72.2%) achieved major response which included 7 (38.8%) complete remission and 6 (33.3%) partial remission after the induction chemotherapy and radiotherapy. 4 (22.2%) had progressive disease. Another 3 (16.6%) attained complete remission after post radiation chemotherapy which consisted of two cycles of cisplatin and 5-flourouracil. The follow up ranged from 5 months to 84 months with a median follow up of 35 months. The disease free survival ranged from 10 months to 53 months with a median of 33 months. The patients who had a better response to induction chemotherapy had a better disease free survival. Out of 7 patients who attained complete remission 2 relapsed with a median time to first relapse of 9.5 months. Toxicity to therapy was modest. Only one patient had grade 4 neutropenia and mucositis. There was no therapy related mortality. Conclusion: Chemoradiotherapy for nasopharyngeal carcinoma in children is an effective treatment modality with minimal toxicity. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- A. A. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - P. M. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - K. M. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. N. Shukla
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - B. J. Parikh
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. S. Anand
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. A. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. S. Talati
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - H. P. Panchal
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - R. Pandey
- Gujarat Cancer and Research Institute, Ahmedabad, India
| |
Collapse
|
32
|
Pandey R, Patel AA, Shah SA, Patel KM, Shah PM, Shukla SN, Parikh BJ, Anand AS, Talati SS, Panchal HP. Central venous access in the pediatric cancer patient—Problems unique to developing countries: 5-year experience at a regional cancer center in Western India. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.9049] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
9049 Background: Central venous catheter (CVC) is required in the pediatric cancer patient for chemotherapy administration and supportive care. This study was carried out to review our experience with CVC, with special reference to issues unique to developing countries. Methods: 178 children who underwent 181 CVC insertions at our institute between January 2001 and October 2005 were retrospectively analysed for demographics, diagnosis, type of CVC, infective and non infective complications. Continuous data were assessed using the t test or the Wilcoxon rank sum test and categorical data by the chi square test or the Fisher’s exact test. Results: Median age was 6.5 years (0.6–13 yr). Commonest diagnosis was acute lymphoid leukemia (ALL) (n=60). CVC used were Hickman (n=162), subcutaneous ports (n=9) and peripherally inserted central catheters (n=10). Patients with hickman catheters had 164 insertions for 162 patients with a total of 14,090 catheter days, an average of 86.9 days/catheter. There were 5.36 culture positive infections /1000 catheter days. The commonest isolate was Coagulase negative S. Aureus (CNS) (44/80 cases). CVC infection with CNS was associated with higher risk of recurrent infections (OR=3.5 {95%CI=2.12–8.23} p=0.01). Patients having recurrent CVC infections received antibiotics for a median of 9.4 days as against a median of 10 days for those with non-recurrent infections (p=0.01, Wilcoxon rank sum). In 58 ALL patients, early (within 15 days of induction) insertion of CVC was associated with increased risk of culture positive infection as against late (after 15 days of induction) insertion (OR=2.3, 95%CI=1.0–5.2, p=0.05). Other complications were thrombosis (n=3), exit-site infection (n=5), tunnel infection (n=3), catheter fracture (n=1) and dislodgement (n=3). Conclusions: As most patients do not afford port, Hickman is the most preferred CVC in pediatric oncology in a developing country. Most patients are of low literacy and poor socioeconomic status. This is reflected in significantly high rates of CVC infection. Communication between the inserting doctor, nursing staff and proper counseling of the patient is the key to reduce complications No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Pandey
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. A. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. A. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - K. M. Patel
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - P. M. Shah
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. N. Shukla
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - B. J. Parikh
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - A. S. Anand
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - S. S. Talati
- Gujarat Cancer and Research Institute, Ahmedabad, India
| | - H. P. Panchal
- Gujarat Cancer and Research Institute, Ahmedabad, India
| |
Collapse
|
33
|
Abstract
A hybrid cellular automaton model is described and used to simulate early tumor growth and examine the roles of host tissue vascular density and tumor metabolism in the ability of a small number of monoclonal transformed cells to develop into an invasive tumor. The model incorporates normal cells, tumor cells, necrotic or empty space, and a random network of native microvessels as components of a cellular automaton state vector. Diffusion of glucose and H(+)ions (the latter largely resulting from the tumor's excessive reliance on anaerobic metabolism) to and from the microvessels, and their utilization or production by cells, is modeled through the solution of differential equations. In this way, the cells and microvessels affect the extracellular concentrations of glucose and H(+)which, in turn, affect the evolution of the automaton. Simulations of the model demonstrate that: (i) high tumor H(+)ion production is favorable for tumor growth and invasion; however for every H(+)ion production rate, there exists a range of optimal microvessel densities (leading to a local pH favorable to tumor but not to normal cells) for which growth and invasion is most effective, (ii) at vascular densities below this range, both tumor and normal cells die due to excessively low pH, (iii) for vascular densities above the optimal range the microvessel network is highly efficient at removing acid and therefore the tumor cells lose their advantage over normal cells gained by high local H(+)concentration. While significant spatial gradients of glucose formed, no regions of detrimentally poor glucose perfusion (for either cell type) were observed, regardless of microvessel density. Depending on metabolic phenotype, a variety of tumor morphologies similar to those clinically observed were realized in the simulations. Lastly, a sharp transition (analogous to that of the adenoma-carcinoma sequence) between states of initial tumor confinement and efficient invasiveness was observed when H(+)production reached a critical value.
Collapse
Affiliation(s)
- A A Patel
- Department of Interventional Radiology, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
| | | | | | | |
Collapse
|
34
|
Nathan JD, Patel AA, McVey DC, Thomas JE, Prpic V, Vigna SR, Liddle RA. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 2001; 281:G1322-8. [PMID: 11668042 DOI: 10.1152/ajpgi.2001.281.5.g1322] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
We examined whether the capsaicin vanilloid receptor-1 (VR1) mediates substance P (SP) release from primary sensory neurons in experimental pancreatitis. Pancreatitis was achieved by 12 hourly injections of caerulein (50 microg/kg ip) in mice. One group received capsazepine (100 micromol/kg sc), a competitive VR1 antagonist, at 4-h intervals. Neurokinin-1 receptor (NK1R) internalization in acinar cells, used as an index of endogenous SP release, was assessed by immunocytochemical quantification of NK1R endocytosis. The severity of pancreatitis was assessed by measurements of serum amylase, pancreatic myeloperoxidase (MPO) activity, and histological grading. Caerulein administration caused significant elevations in serum amylase and pancreatic MPO activity, produced histological evidence of pancreatitis, and caused a dramatic increase in NK1R endocytosis. Capsazepine treatment significantly reduced the level of NK1R endocytosis, and this was associated with similar reductions in pancreatic MPO activity and histological severity of pancreatitis. These results demonstrate that repeated caerulein stimulation causes experimental pancreatitis that is mediated in part by stimulation of VR1 on primary sensory neurons, resulting in endogenous SP release.
Collapse
Affiliation(s)
- J D Nathan
- Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
| | | | | | | | | | | | | |
Collapse
|
35
|
Patel AA, Hatle L, Mimish L. Pulmonary stenosis and severe biventricular dysfunction: improvement following percutaneous valvuloplasty. J Heart Valve Dis 1999; 8:307-11. [PMID: 10399667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
A 15-year-old boy with severe pulmonary stenosis associated with severe right and left ventricular systolic dysfunction is reported. After successful percutaneous pulmonary valvuloplasty, there was an initial and early improvement in right ventricular (RV) function, followed by a delayed and more gradual improvement in left ventricular (LV) function. At long-term follow up, both RV and LV systolic functions were nearly normalized. Several mechanisms may be implicated, including ventricular interdependence, geometric factors, altered compliance and intrinsic alteration in the LV muscle. A delayed, but sustained, improvement in LV systolic function following relief of RV pressure overload suggests that the latter mechanism must have played an important role in the genesis of the LV dysfunction. Pulmonary stenosis associated with severe biventricular dysfunction may be treated primarily by percutaneous pulmonary balloon valvuloplasty with near-total recovery of the ventricular function.
Collapse
Affiliation(s)
- A A Patel
- King Faisal Specialist Hospital and Research Center, Department of Cardiovascular Diseases, Riyadh, Saudi Arabia
| | | | | |
Collapse
|
36
|
Abstract
Infection with the human immunodeficiency virus (HIV) is increasing in prevalence, and disease patterns are changing as patient survival lengthens. The purpose of this cross-sectional epidemiological study was to assess the prevalence and severity of self-reported symptoms of otolaryngologic disease in a group of patients attending a general HIV outpatient clinic (n = 203), and to compare the prevalence of self-reported symptoms with a sample of patients without HIV infection (n = 100). Of the HIV-infected patients, 65% of patients had AIDS, 35% were HIV-positive, and the median CD4 count was 135. Although only 11% of patients had seen an otolaryngologist in the prior 6 months, the majority of patients (66%) reported the presence of sinonasal disease during that time. Allergic rhinitis (80%) and sinusitis (54%) were the most commonly reported sinonasal symptoms, and 44% regularly used nasal or sinus medications. Sinonasal disease severity was significantly higher than the self-reported severity of mouth/throat disease (p = 0.01), ear disease (p = 0.03), and neck/salivary disease (p = 0.01). Although patients' self-reported overall health status was associated (p = 0.02) with CD4 count, the severity of sinonasal symptoms was not associated (p = 0.93) with CD4 count. Similarly, sinonasal symptom severity did not differ between HIV-positive and AIDS patients (p = 0.45). In other words, sinonasal disease severity did not improve as general health status improved.
Collapse
Affiliation(s)
- J P Porter
- Bobby R. Alford Department of Otorhinolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | | | |
Collapse
|
37
|
Oghalai JS, Patel AA, Nakagawa T, Brownell WE. Fluorescence-imaged microdeformation of the outer hair cell lateral wall. J Neurosci 1998; 18:48-58. [PMID: 9412485 PMCID: PMC6793406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Outer hair cell (OHC) electromotility appears to be central to mammalian hearing and originates within its lateral wall. The OHC lateral wall is a unique trilaminate structure consisting of the plasma membrane (PM), the cortical lattice (CL), and the subsurface cisternae (SSC). We selectively labeled and imaged the lateral wall components in the isolated guinea pig OHC under confocal microscopy. The PM was labeled with a voltage-sensitive dye, di-8-ANEPPS; the SSC was labeled with the sphingomyelin precursor, NBD-C6-ceramide; and F-actin in the CL was labeled with conjugates of phalloidin. Interactions among the three layers were evaluated with the micropipette aspiration technique. The PM was tethered to the CL and SSC until, at a critical deformation pressure, the PM separated, allowing visualization of the extracisternal space, and ultimately formed a vesicle. After detaching, the stiffness parameter of the PM was 22% of that of the intact lateral wall. We conclude that the lateral wall PM is more compliant than the CL/SSC complex. The data clarify the structural basis for electromotile force coupling in the OHC lateral wall.
Collapse
Affiliation(s)
- J S Oghalai
- Bobby R. Alford Department of Otorhinolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | | | |
Collapse
|
38
|
Ross CN, Gaskin G, Gregor-Macgregor S, Patel AA, Davey NJ, Lechler RI, Williams G, Rees AJ, Pusey CD. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 1993; 55:785-9. [PMID: 8475552 DOI: 10.1097/00007890-199304000-00019] [Citation(s) in RCA: 59] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Five highly sensitized patients, with panel reactivity greater than 80% for 1.75-5 years, were treated by extracorporeal staphylococcal protein-A immunoadsorption, prednisolone, and cyclophosphamide. The five patients underwent treatment of 18-40 (mean 31) liters of plasma, respectively in 4-7 (mean 5.6) sessions. This reduced the titer of cytotoxic antibodies to sensitizing antigens to < 1/8 in all cases and abolished reactivity to crossreacting antigens. Two patients required retreatment following resynthesis of cytotoxic antibodies. All five patients have been transplanted, and four of these now have stable serum creatinines of 168 mumol/L at 34 months, 208 mumol/L at 29 months, 96 mumol/L at 5 months, and 125 mumol/L at 3 months posttransplantation. One patient had primary graft dysfunction due to acute tubular necrosis; the kidney was removed after eight weeks and showed cortical necrosis without evidence of acute rejection.
Collapse
Affiliation(s)
- C N Ross
- Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, England
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Abstract
The Chernobyl nuclear reactor accident in Russia in 1986 has further revealed the susceptibility of the environment to radioactive contamination. This can have serious implications for the safety of milk as well as other foods. Global fallout and other isotope releases can threaten to increase the radionuclide levels in milk alarmingly, and thus make it unfit for human consumption. Perception of such fears in the past resulted in considerable research efforts being directed towards radioactive decontamination of milk by different means. The holding of milk and milk products long enough to deactivate certain radioisotopes prior to consumption, conversion of milk into butter, and manufacturing cheese by using modified processes are some of the approaches in minimizing the radioactivity risk to consumers. Extensive studies carried out in the USA have shown that though somewhat expensive, ion-exchange treatment of milk in large-scale, automated plants can eliminate 90% or more of the radionuclides of concern, i.e. strontium-90, and iodine-131, and much of caesium-137. Various factors affecting the efficiency of the ion exchange process and properties of the treated milk are reviewed. Other processing techniques such as electrodialysis are also briefly discussed in relation to removal of radionuclides from milk.
Collapse
Affiliation(s)
- A A Patel
- Institut für Lebensmittelverfahrenstechnik, Technische Universität München, Germany
| | | |
Collapse
|
40
|
Patel RB, Patel MR, Patel AA, Shah AK, Patel AG. Separation and determination of food colours in pharmaceutical preparations by column chromatography. Analyst 1986; 111:577-8. [PMID: 3740429 DOI: 10.1039/an9861100577] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
41
|
Abstract
Soymilk obtained through blanching and grinding of soaked beans was examined for its suitability for fermentation with certain lactic cultures. Acid production as well as flavor and texture characteristics of the fermented soymilk were substantially improved by lactose fortification. Citrated soymilk on culturing, had a slightly improved flavor. Cultured whey-soymilk had a slightly weaker consistency but better flavor than lactose-enriched soymilk.
Collapse
Affiliation(s)
- A A Patel
- Division of Dairy Technology, National Dairy Research Institute, Karnal-132001, India
| | - S K Gupta
- Division of Dairy Technology, National Dairy Research Institute, Karnal-132001, India
| |
Collapse
|
42
|
Patel RB, Gandhi TP, Shah GF, Patel AA, Patel VC. The effect of riboflavin tetrabutyrate on lipoperoxide content of oils and experimental hyperlipaemia on rats and rabbits and its comparison with clofibrate. J Assoc Physicians India 1978; 26:989-94. [PMID: 752678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
43
|
|
44
|
Patel AA, Rao SS. Action of tetanus toxin on brain, liver and muscle mitochondria from resistant and susceptible species. Br J Pharmacol Chemother 1966; 26:730-9. [PMID: 5959215 PMCID: PMC1510696 DOI: 10.1111/j.1476-5381.1966.tb01853.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
45
|
Patel AA, Rao SS. Subcellular fixation of tetanus toxin in susceptible and resistant species. Br J Pharmacol Chemother 1966; 26:740-7. [PMID: 5959216 PMCID: PMC1510702 DOI: 10.1111/j.1476-5381.1966.tb01854.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
46
|
Patel AA, Rao SS. Action of adrenaline on tetanus toxin. Indian J Med Sci 1965; 19:818-20. [PMID: 5850232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
47
|
Patel AA, Rao SS. Action of tetanus toxin on brain and liver mitochondria of resistant and susceptible animals. Indian J Biochem 1965; 2:135-6. [PMID: 4221004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|